Gain Therapeutics, Inc. financial data

Symbol
GANX on Nasdaq
Industry
Pharmaceutical Preparations
Location
4800 Hampden Lane, Suite 200, Bethesda, Maryland
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 292 % -45.2%
Debt-to-equity 65.3 % +149%
Return On Equity -213 % -129%
Return On Assets -129 % -75.2%
Operating Margin -40.3 K % -218%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 18.1 M shares +46.4%
Common Stock, Shares, Outstanding 18 M shares +49.3%
Entity Public Float 56.6 M USD +45.9%
Common Stock, Value, Issued 1.81 K USD +49.3%
Weighted Average Number of Shares Outstanding, Basic 18 M shares +50.6%
Weighted Average Number of Shares Outstanding, Diluted 18 M shares +50.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 55.2 K USD -60.6%
Revenue from Contract with Customer, Excluding Assessed Tax 55.2 K USD -58.4%
Research and Development Expense 11.2 M USD +16.9%
General and Administrative Expense 10.2 M USD -0.9%
Operating Income (Loss) -21.4 M USD -8.53%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -21.1 M USD -8.86%
Income Tax Expense (Benefit) 82.4 K USD -23.7%
Net Income (Loss) Attributable to Parent -21.1 M USD -8.68%
Earnings Per Share, Basic -1.5 USD/shares +7.98%
Earnings Per Share, Diluted -1.5 USD/shares +7.98%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 10.6 M USD +77.7%
Marketable Securities, Current 2.02 M USD -82.9%
Cash, Cash Equivalents, and Short-term Investments 12.7 M USD
Assets, Current 13.9 M USD -28.3%
Property, Plant and Equipment, Net 112 K USD -22.6%
Operating Lease, Right-of-Use Asset 384 K USD -37%
Assets 14.6 M USD -31.6%
Accounts Payable, Current 1.41 M USD -36.5%
Accrued Liabilities, Current 1.1 M USD -12.7%
Liabilities, Current 5 M USD -2.93%
Operating Lease, Liability, Noncurrent 177 K USD -54%
Liabilities 5.94 M USD -4.02%
Accumulated Other Comprehensive Income (Loss), Net of Tax 21.9 K USD -77.3%
Retained Earnings (Accumulated Deficit) -60.8 M USD -57.8%
Stockholders' Equity Attributable to Parent 8.64 M USD -42.9%
Liabilities and Equity 14.6 M USD -31.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.59 M USD +15%
Net Cash Provided by (Used in) Financing Activities -146 K USD -119%
Net Cash Provided by (Used in) Investing Activities 3.02 M USD +43.3%
Common Stock, Shares Authorized 50 M shares 0%
Common Stock, Shares, Issued 18 M shares +49.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.16 M USD +12.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 10.7 M USD +77.3%
Deferred Tax Assets, Valuation Allowance 12 M USD +27.5%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 12.1 M USD +27.4%
Operating Lease, Liability 382 K USD -38.2%
Depreciation 8 K USD 0%
Payments to Acquire Property, Plant, and Equipment 7.83 K USD -72.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -21.2 M USD -10.3%
Lessee, Operating Lease, Liability, to be Paid 388 K USD
Property, Plant and Equipment, Gross 210 K USD +1.26%
Operating Lease, Liability, Current 205 K USD -12%
Operating Lease, Weighted Average Discount Rate, Percent 0.02 pure 0%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) 79.3 K USD -14.7%
Preferred Stock, Shares Authorized 10 M shares 0%
Additional Paid in Capital 73.4 M USD +25.1%
Preferred Stock, Shares Outstanding 0 shares
Operating Leases, Future Minimum Payments, Due in Two Years 175 K USD -22.2%
Depreciation, Depletion and Amortization 20.5 K USD +6.68%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 235 K USD -3.4%
Share-based Payment Arrangement, Expense 2.88 M USD +61.5%
Operating Leases, Future Minimum Payments, Due in Three Years 57.9 K USD -64.9%
Operating Leases, Future Minimum Payments Due 467 K USD -31.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%